Beste apotheek van Nederland

(117) Carrier S, Brock GB, Pommerville PJ et al.
Efficacy and safety of oral tadalafil in the
treatment of men in canada with erectile
dysfunction: A randomized, double-blind,
parallel, placebo-controlled clinical trial. J
Sex Med 2005; 2(5):685-698.
(118) Carson C, Shabsigh R, Segal S et al.
Efficacy, safety, and treatment satisfaction
of tadalafil versus placebo in patients with
erectile dysfunction evaluated at tertiarycare
academic centers. Urology 2005;
65(2):353-359.
(119) Chen KK, Jiann B-P, Lin JSN et al. Efficacy
and safety of on-demand oral tadalafil in the
treatment of men with erectile dysfunction
in Taiwan: A randomized, double-blind,
parallel, placebo-controlled clinical study. J
Sex Med 2004; 1(2):201-208.
(120) Choi H-K, Kim JJ, Kim S-C et al. A
randomised, double-blind, parallel, placebocontrolled
study of the efficacy and safety of
Tadalafil administered on-demand to men
with erectile dysfunction in Korea. Taehan
Pinyogikwa Hakhoe Chapchi 2006;
(121) De Rose AF, Gallo F, Carmignani G.
Evaluation of sexual activity in patients
treated with tadalafil: a randomized
prospective placebo-controlled trial. Int J
Impot Res 2005; 17(1):76-79.
controlled, cross-over study to assess the
efficacy of tadalafil (Cialis) in the treatment
of erectile dysfunction following threedimensional
conformal external-beam
radiotherapy for prostatic carcinoma. Int J
Radiat Oncol Biol Phys 2006; 66(2):439-
444.
(126) McMahon CG, Stuckey BG, Lording DW et
al. A 6-month study of the efficacy and
safety of tadalafil in the treatment of erectile
dysfunction: a randomised, double-blind,
parallel-group, placebo-controlled study in
Australian men. Int J Clin Pract 2005;
59(2):143-149.
(127) McMahon C, Kloner RA, Hutter Jr AM et
al. Comparison of efficacy, safety, and
tolerability of on-demand tadalafil and daily
dosed tadalafil for the treatment of erectile
dysfunction. J Sex Med 2005; 2(3):415-427.
(128) McVary KT, Roehrborn CG, Kaminetsky JC
et al. Tadalafil relieves lower urinary tract
symptoms secondary to benign prostatic
hyperplasia. J Urol 2007; 177(4):1401-1407.
47(8):852-858. (129) Mirone V, Costa P, Damber JE et al. An
evaluation of an alternative dosing regimen
with tadalafil, 3 times/week, for men with
erectile dysfunction: SURE study in 14
European countries. Eur Urol 2005;
47(6):846-854.
(122) Eardley I, Gentile V, Austoni E et al.
Efficacy and safety of tadalafil in a Western
European population of men with erectile
dysfunction. BJU Int 2004; 94(6):871-877.
(123) Govier F, Potempa AJ, Kaufman J et al. A
multicenter, randomized, double-blind,
crossover study of patient preference for
tadalafil 20 mg or sildenafil citrate 50 mg
during initiation of treatment for erectile
dysfunction. Eur Urol 2003; 25(11):2709-
2723.
(124) Guo YL, Zhu JC, Pan TM et al. Efficacy and
safety of on-demand tadalafil for the
treatment of erectile dysfunction in South-
East Asian men. Int J Urol 2006; 13(6):721-
727.
(130) Moncada I, Damber J-E, Mirone V et al.
Sexual intercourse attempt patterns with two
dosing regimens of tadalafil in men with
erectile dysfunction: Results from the SURE
study in 14 European countries. J Sex Med
2005; 2(5):668-674.
(131) Montorsi F, Nathan HP, McCullough A et
al. Tadalafil in the treatment of erectile
dysfunction following bilateral nerve
sparing radical retropubic prostatectomy: a
randomized, double-blind, placebo
controlled trial.[erratum appears in J Urol.
2005 Feb;173(2):664]. J Urol 2004;
172(3):1036-1041.
(132) Nagao K, Kimoto Y, Marumo K et al.
Efficacy and safety of tadalafil 5, 10, and 20
mg in Japanese men with erectile
dysfunction: results of a multicenter,
(125) Incrocci L, Slagter C, Slob AK et al. A randomized, double-blind, placeborandomized,
double-blind, placebo-
C-264